Josepmaria Argemi

20PUBLICATIONS
127CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Health counselling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Mar 19, 2026
Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy.

Belén Aparicio, Leyre Silva, Marta Ruiz

|Oct 21, 2025
Pan-microbial serological repertoire as a biomarker of immunotherapy response in hepatocellular carcinoma.

Shay Behrens, Whitney Leet Do, Limin Wang

|Sep 13, 2025
Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next?

Lucía Ceniceros, Manuel de La Torre, Ana Landa Magdalena

|Jun 26, 2025
Multi-Cohort Exploration of Repetitive Element Transcription and DNA Methylation in Human Steatotic Liver Disease.

Neil A Youngson, Aikaterini Tourna, Timothy Chalmers

|Mar 13, 2025
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3.

Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang

|Dec 06, 2024
Modulatory effects of CNNM4 on protein- l -isoaspartyl- O -methyltransferase repair function during alcohol-induced hepatic damage.

Irene González-Recio, Naroa Goikoetxea-Usandizaga, Claudia M Rejano-Gordillo

Pageof 4

Frequent Collaborators

6 joint publications

Bruno Sangro

5 joint publications

Ramón Bataller

4 joint publications

Meritxell Ventura-Cots

4 joint publications

Ramon Bataller